VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen's three drug candidates, PH94B, PH10, and AV-101, has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets.
343 Allerton Avenue
South San Francisco, CA 94080
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical Preparations (2834)